Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
766
archived clinical trials in
Cosmetic

Safety and Efficacy of Azelaic Acid Foam, 15 % in Papulopustular Rosacea
A Randomized, Double-blind, Vehicle-controlled, Multicenter, Parallel-group Clinical Trial to Assess the Safety and Efficacy of Azelaic Acid Foam, 15% Topically Applied Twice Daily for 12 Weeks in Subjects With Papulopustular Rosacea
Status: Enrolling
Updated:  12/28/2015
Clinical Research Facility
mi
from
Stony Brook, NY
Safety and Efficacy of Azelaic Acid Foam, 15 % in Papulopustular Rosacea
A Randomized, Double-blind, Vehicle-controlled, Multicenter, Parallel-group Clinical Trial to Assess the Safety and Efficacy of Azelaic Acid Foam, 15% Topically Applied Twice Daily for 12 Weeks in Subjects With Papulopustular Rosacea
Status: Enrolling
Updated: 12/28/2015
Clinical Research Facility
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Safety and Efficacy of Azelaic Acid Foam, 15 % in Papulopustular Rosacea
A Randomized, Double-blind, Vehicle-controlled, Multicenter, Parallel-group Clinical Trial to Assess the Safety and Efficacy of Azelaic Acid Foam, 15% Topically Applied Twice Daily for 12 Weeks in Subjects With Papulopustular Rosacea
Status: Enrolling
Updated:  12/28/2015
Clinical Research Facility
mi
from
Chapel Hill, NC
Safety and Efficacy of Azelaic Acid Foam, 15 % in Papulopustular Rosacea
A Randomized, Double-blind, Vehicle-controlled, Multicenter, Parallel-group Clinical Trial to Assess the Safety and Efficacy of Azelaic Acid Foam, 15% Topically Applied Twice Daily for 12 Weeks in Subjects With Papulopustular Rosacea
Status: Enrolling
Updated: 12/28/2015
Clinical Research Facility
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Safety and Efficacy of Azelaic Acid Foam, 15 % in Papulopustular Rosacea
A Randomized, Double-blind, Vehicle-controlled, Multicenter, Parallel-group Clinical Trial to Assess the Safety and Efficacy of Azelaic Acid Foam, 15% Topically Applied Twice Daily for 12 Weeks in Subjects With Papulopustular Rosacea
Status: Enrolling
Updated:  12/28/2015
Clinical Research Facility
mi
from
Hickory, NC
Safety and Efficacy of Azelaic Acid Foam, 15 % in Papulopustular Rosacea
A Randomized, Double-blind, Vehicle-controlled, Multicenter, Parallel-group Clinical Trial to Assess the Safety and Efficacy of Azelaic Acid Foam, 15% Topically Applied Twice Daily for 12 Weeks in Subjects With Papulopustular Rosacea
Status: Enrolling
Updated: 12/28/2015
Clinical Research Facility
mi
from
Hickory, NC
Click here to add this to my saved trials
Safety and Efficacy of Azelaic Acid Foam, 15 % in Papulopustular Rosacea
A Randomized, Double-blind, Vehicle-controlled, Multicenter, Parallel-group Clinical Trial to Assess the Safety and Efficacy of Azelaic Acid Foam, 15% Topically Applied Twice Daily for 12 Weeks in Subjects With Papulopustular Rosacea
Status: Enrolling
Updated:  12/28/2015
Clinical Research Facility
mi
from
High Point, NC
Safety and Efficacy of Azelaic Acid Foam, 15 % in Papulopustular Rosacea
A Randomized, Double-blind, Vehicle-controlled, Multicenter, Parallel-group Clinical Trial to Assess the Safety and Efficacy of Azelaic Acid Foam, 15% Topically Applied Twice Daily for 12 Weeks in Subjects With Papulopustular Rosacea
Status: Enrolling
Updated: 12/28/2015
Clinical Research Facility
mi
from
High Point, NC
Click here to add this to my saved trials
Safety and Efficacy of Azelaic Acid Foam, 15 % in Papulopustular Rosacea
A Randomized, Double-blind, Vehicle-controlled, Multicenter, Parallel-group Clinical Trial to Assess the Safety and Efficacy of Azelaic Acid Foam, 15% Topically Applied Twice Daily for 12 Weeks in Subjects With Papulopustular Rosacea
Status: Enrolling
Updated:  12/28/2015
Clinical Research Facility
mi
from
Raleigh, NC
Safety and Efficacy of Azelaic Acid Foam, 15 % in Papulopustular Rosacea
A Randomized, Double-blind, Vehicle-controlled, Multicenter, Parallel-group Clinical Trial to Assess the Safety and Efficacy of Azelaic Acid Foam, 15% Topically Applied Twice Daily for 12 Weeks in Subjects With Papulopustular Rosacea
Status: Enrolling
Updated: 12/28/2015
Clinical Research Facility
mi
from
Raleigh, NC
Click here to add this to my saved trials
Safety and Efficacy of Azelaic Acid Foam, 15 % in Papulopustular Rosacea
A Randomized, Double-blind, Vehicle-controlled, Multicenter, Parallel-group Clinical Trial to Assess the Safety and Efficacy of Azelaic Acid Foam, 15% Topically Applied Twice Daily for 12 Weeks in Subjects With Papulopustular Rosacea
Status: Enrolling
Updated:  12/28/2015
Clinical Research Facility
mi
from
Winston-Salem, NC
Safety and Efficacy of Azelaic Acid Foam, 15 % in Papulopustular Rosacea
A Randomized, Double-blind, Vehicle-controlled, Multicenter, Parallel-group Clinical Trial to Assess the Safety and Efficacy of Azelaic Acid Foam, 15% Topically Applied Twice Daily for 12 Weeks in Subjects With Papulopustular Rosacea
Status: Enrolling
Updated: 12/28/2015
Clinical Research Facility
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Safety and Efficacy of Azelaic Acid Foam, 15 % in Papulopustular Rosacea
A Randomized, Double-blind, Vehicle-controlled, Multicenter, Parallel-group Clinical Trial to Assess the Safety and Efficacy of Azelaic Acid Foam, 15% Topically Applied Twice Daily for 12 Weeks in Subjects With Papulopustular Rosacea
Status: Enrolling
Updated:  12/28/2015
Clinical Research Facility
mi
from
Johnston, RI
Safety and Efficacy of Azelaic Acid Foam, 15 % in Papulopustular Rosacea
A Randomized, Double-blind, Vehicle-controlled, Multicenter, Parallel-group Clinical Trial to Assess the Safety and Efficacy of Azelaic Acid Foam, 15% Topically Applied Twice Daily for 12 Weeks in Subjects With Papulopustular Rosacea
Status: Enrolling
Updated: 12/28/2015
Clinical Research Facility
mi
from
Johnston, RI
Click here to add this to my saved trials
Safety and Efficacy of Azelaic Acid Foam, 15 % in Papulopustular Rosacea
A Randomized, Double-blind, Vehicle-controlled, Multicenter, Parallel-group Clinical Trial to Assess the Safety and Efficacy of Azelaic Acid Foam, 15% Topically Applied Twice Daily for 12 Weeks in Subjects With Papulopustular Rosacea
Status: Enrolling
Updated:  12/28/2015
Clinical Research Facility
mi
from
Anderson, SC
Safety and Efficacy of Azelaic Acid Foam, 15 % in Papulopustular Rosacea
A Randomized, Double-blind, Vehicle-controlled, Multicenter, Parallel-group Clinical Trial to Assess the Safety and Efficacy of Azelaic Acid Foam, 15% Topically Applied Twice Daily for 12 Weeks in Subjects With Papulopustular Rosacea
Status: Enrolling
Updated: 12/28/2015
Clinical Research Facility
mi
from
Anderson, SC
Click here to add this to my saved trials
Safety and Efficacy of Azelaic Acid Foam, 15 % in Papulopustular Rosacea
A Randomized, Double-blind, Vehicle-controlled, Multicenter, Parallel-group Clinical Trial to Assess the Safety and Efficacy of Azelaic Acid Foam, 15% Topically Applied Twice Daily for 12 Weeks in Subjects With Papulopustular Rosacea
Status: Enrolling
Updated:  12/28/2015
Clinical Research Facility
mi
from
Knoxville, TN
Safety and Efficacy of Azelaic Acid Foam, 15 % in Papulopustular Rosacea
A Randomized, Double-blind, Vehicle-controlled, Multicenter, Parallel-group Clinical Trial to Assess the Safety and Efficacy of Azelaic Acid Foam, 15% Topically Applied Twice Daily for 12 Weeks in Subjects With Papulopustular Rosacea
Status: Enrolling
Updated: 12/28/2015
Clinical Research Facility
mi
from
Knoxville, TN
Click here to add this to my saved trials
Safety and Efficacy of Azelaic Acid Foam, 15 % in Papulopustular Rosacea
A Randomized, Double-blind, Vehicle-controlled, Multicenter, Parallel-group Clinical Trial to Assess the Safety and Efficacy of Azelaic Acid Foam, 15% Topically Applied Twice Daily for 12 Weeks in Subjects With Papulopustular Rosacea
Status: Enrolling
Updated:  12/28/2015
Clinical Research Facility
mi
from
Austin, TX
Safety and Efficacy of Azelaic Acid Foam, 15 % in Papulopustular Rosacea
A Randomized, Double-blind, Vehicle-controlled, Multicenter, Parallel-group Clinical Trial to Assess the Safety and Efficacy of Azelaic Acid Foam, 15% Topically Applied Twice Daily for 12 Weeks in Subjects With Papulopustular Rosacea
Status: Enrolling
Updated: 12/28/2015
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
Safety and Efficacy of Azelaic Acid Foam, 15 % in Papulopustular Rosacea
A Randomized, Double-blind, Vehicle-controlled, Multicenter, Parallel-group Clinical Trial to Assess the Safety and Efficacy of Azelaic Acid Foam, 15% Topically Applied Twice Daily for 12 Weeks in Subjects With Papulopustular Rosacea
Status: Enrolling
Updated:  12/28/2015
Clinical Research Facility
mi
from
Plano, TX
Safety and Efficacy of Azelaic Acid Foam, 15 % in Papulopustular Rosacea
A Randomized, Double-blind, Vehicle-controlled, Multicenter, Parallel-group Clinical Trial to Assess the Safety and Efficacy of Azelaic Acid Foam, 15% Topically Applied Twice Daily for 12 Weeks in Subjects With Papulopustular Rosacea
Status: Enrolling
Updated: 12/28/2015
Clinical Research Facility
mi
from
Plano, TX
Click here to add this to my saved trials
Safety and Efficacy of Azelaic Acid Foam, 15 % in Papulopustular Rosacea
A Randomized, Double-blind, Vehicle-controlled, Multicenter, Parallel-group Clinical Trial to Assess the Safety and Efficacy of Azelaic Acid Foam, 15% Topically Applied Twice Daily for 12 Weeks in Subjects With Papulopustular Rosacea
Status: Enrolling
Updated:  12/28/2015
Clinical Research Facility
mi
from
Webster, TX
Safety and Efficacy of Azelaic Acid Foam, 15 % in Papulopustular Rosacea
A Randomized, Double-blind, Vehicle-controlled, Multicenter, Parallel-group Clinical Trial to Assess the Safety and Efficacy of Azelaic Acid Foam, 15% Topically Applied Twice Daily for 12 Weeks in Subjects With Papulopustular Rosacea
Status: Enrolling
Updated: 12/28/2015
Clinical Research Facility
mi
from
Webster, TX
Click here to add this to my saved trials
Safety and Efficacy of Azelaic Acid Foam, 15 % in Papulopustular Rosacea
A Randomized, Double-blind, Vehicle-controlled, Multicenter, Parallel-group Clinical Trial to Assess the Safety and Efficacy of Azelaic Acid Foam, 15% Topically Applied Twice Daily for 12 Weeks in Subjects With Papulopustular Rosacea
Status: Enrolling
Updated:  12/28/2015
Clinical Research Facility
mi
from
Salt Lake City, UT
Safety and Efficacy of Azelaic Acid Foam, 15 % in Papulopustular Rosacea
A Randomized, Double-blind, Vehicle-controlled, Multicenter, Parallel-group Clinical Trial to Assess the Safety and Efficacy of Azelaic Acid Foam, 15% Topically Applied Twice Daily for 12 Weeks in Subjects With Papulopustular Rosacea
Status: Enrolling
Updated: 12/28/2015
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Safety and Efficacy of Azelaic Acid Foam, 15 % in Papulopustular Rosacea
A Randomized, Double-blind, Vehicle-controlled, Multicenter, Parallel-group Clinical Trial to Assess the Safety and Efficacy of Azelaic Acid Foam, 15% Topically Applied Twice Daily for 12 Weeks in Subjects With Papulopustular Rosacea
Status: Enrolling
Updated:  12/28/2015
Clinical Research Facility
mi
from
Seattle, WA
Safety and Efficacy of Azelaic Acid Foam, 15 % in Papulopustular Rosacea
A Randomized, Double-blind, Vehicle-controlled, Multicenter, Parallel-group Clinical Trial to Assess the Safety and Efficacy of Azelaic Acid Foam, 15% Topically Applied Twice Daily for 12 Weeks in Subjects With Papulopustular Rosacea
Status: Enrolling
Updated: 12/28/2015
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
Safety and Efficacy of Azelaic Acid Foam, 15 % in Papulopustular Rosacea
A Randomized, Double-blind, Vehicle-controlled, Multicenter, Parallel-group Clinical Trial to Assess the Safety and Efficacy of Azelaic Acid Foam, 15% Topically Applied Twice Daily for 12 Weeks in Subjects With Papulopustular Rosacea
Status: Enrolling
Updated:  12/28/2015
Clinical Research Facility
mi
from
Spokane, WA
Safety and Efficacy of Azelaic Acid Foam, 15 % in Papulopustular Rosacea
A Randomized, Double-blind, Vehicle-controlled, Multicenter, Parallel-group Clinical Trial to Assess the Safety and Efficacy of Azelaic Acid Foam, 15% Topically Applied Twice Daily for 12 Weeks in Subjects With Papulopustular Rosacea
Status: Enrolling
Updated: 12/28/2015
Clinical Research Facility
mi
from
Spokane, WA
Click here to add this to my saved trials
Comparison of Efficacy, Safety and Tolerability of Two Different 810 nm Diode Lasers for Hair Reduction
Side-by-Side Comparison of 810 nm Diode Laser Technology With Low Fluence-High Repetition Rate vs Low Fluence-Vacuum Assist - A Split - Extremity Efficacy , Safety and Tolerability Study
Status: Enrolling
Updated:  1/7/2016
Department of Dermatology Clinical Research
mi
from
Irvine, CA
Comparison of Efficacy, Safety and Tolerability of Two Different 810 nm Diode Lasers for Hair Reduction
Side-by-Side Comparison of 810 nm Diode Laser Technology With Low Fluence-High Repetition Rate vs Low Fluence-Vacuum Assist - A Split - Extremity Efficacy , Safety and Tolerability Study
Status: Enrolling
Updated: 1/7/2016
Department of Dermatology Clinical Research
mi
from
Irvine, CA
Click here to add this to my saved trials
Patient Centered Outcomes in Rosacea: An Exploratory Multi-media Analysis of the Patient Experience on Oracea
Patient Centered Outcomes in Rosacea: An Exploratory Multi-media Analysis of the Patient Experience on Oracea
Status: Enrolling
Updated:  1/20/2016
Stephens & Associates Dallas Research Center
mi
from
Carrollton, TX
Patient Centered Outcomes in Rosacea: An Exploratory Multi-media Analysis of the Patient Experience on Oracea
Patient Centered Outcomes in Rosacea: An Exploratory Multi-media Analysis of the Patient Experience on Oracea
Status: Enrolling
Updated: 1/20/2016
Stephens & Associates Dallas Research Center
mi
from
Carrollton, TX
Click here to add this to my saved trials
Acellular Dermal Matrix in Tissue Expander Breast Reconstruction: A Prospective, Randomized, Clinical Trial Comparing SurgiMend PRS and AlloDerm RTU
Acellular Dermal Matrix in Tissue Expander Breast Reconstruction: A Prospective, Randomized, Clinical Trial Comparing SurgiMend PRS and AlloDerm RTU
Status: Enrolling
Updated:  2/8/2016
UPMC Center for Innovation in Restorative Medicine
mi
from
Pittsburgh, PA
Acellular Dermal Matrix in Tissue Expander Breast Reconstruction: A Prospective, Randomized, Clinical Trial Comparing SurgiMend PRS and AlloDerm RTU
Acellular Dermal Matrix in Tissue Expander Breast Reconstruction: A Prospective, Randomized, Clinical Trial Comparing SurgiMend PRS and AlloDerm RTU
Status: Enrolling
Updated: 2/8/2016
UPMC Center for Innovation in Restorative Medicine
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Prospective Pellevé™ Neck Wrinkle Study
Prospective Pellevé™ Neck Wrinkle Study
Status: Enrolling
Updated:  2/12/2016
Moy-Fincher-Chipps Facial Plastics/Dermatology
mi
from
Beverly Hills, CA
Prospective Pellevé™ Neck Wrinkle Study
Prospective Pellevé™ Neck Wrinkle Study
Status: Enrolling
Updated: 2/12/2016
Moy-Fincher-Chipps Facial Plastics/Dermatology
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Efficacy and Safety of AGN-199201 in Patients With Persistent Erythema Associated With Rosacea
Status: Enrolling
Updated:  2/12/2016
Clinical Research Facility
mi
from
Lynchburg, VA
Efficacy and Safety of AGN-199201 in Patients With Persistent Erythema Associated With Rosacea
Status: Enrolling
Updated: 2/12/2016
Clinical Research Facility
mi
from
Lynchburg, VA
Click here to add this to my saved trials
Cell Therapy for Craniofacial Bone Defects
Cell Therapy for Craniofacial Bone Defects
Status: Enrolling
Updated:  2/15/2016
Michigan Center for Oral Health Research
mi
from
Ann Arbor, MI
Cell Therapy for Craniofacial Bone Defects
Cell Therapy for Craniofacial Bone Defects
Status: Enrolling
Updated: 2/15/2016
Michigan Center for Oral Health Research
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
IV Acetaminophen in Children Undergoing Palatoplasty
A Prospective, Double-Blinded, Randomized Comparison of Intravenous Acetaminophen Versus Placebo in Children Undergoing Palatoplasty
Status: Enrolling
Updated:  3/4/2016
Nationwide Children's Hospital
mi
from
Columbus, OH
IV Acetaminophen in Children Undergoing Palatoplasty
A Prospective, Double-Blinded, Randomized Comparison of Intravenous Acetaminophen Versus Placebo in Children Undergoing Palatoplasty
Status: Enrolling
Updated: 3/4/2016
Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Comparison of Retinol 1.0% and Tretinoin 0.02% in the Treatment of Moderate to Severe Photodamage and Wrinkles
Double-blinded, Single-center, Parallel-arm Comparison Study of Retinol 1.0% and Tretinoin 0.02% in the Treatment of Moderate to Severe Photodamage
Status: Enrolling
Updated:  3/7/2016
Johns Hopkins Dept. of Dermatology
mi
from
Baltimore, MD
Comparison of Retinol 1.0% and Tretinoin 0.02% in the Treatment of Moderate to Severe Photodamage and Wrinkles
Double-blinded, Single-center, Parallel-arm Comparison Study of Retinol 1.0% and Tretinoin 0.02% in the Treatment of Moderate to Severe Photodamage
Status: Enrolling
Updated: 3/7/2016
Johns Hopkins Dept. of Dermatology
mi
from
Baltimore, MD
Click here to add this to my saved trials
Performance of the ePrime System for Cellulite
Clinical Study to Evaluate the Performance of the ePrime System for the Treatment of Cellulite
Status: Enrolling
Updated:  3/17/2016
Bowes Leyda
mi
from
Miami, FL
Performance of the ePrime System for Cellulite
Clinical Study to Evaluate the Performance of the ePrime System for the Treatment of Cellulite
Status: Enrolling
Updated: 3/17/2016
Bowes Leyda
mi
from
Miami, FL
Click here to add this to my saved trials
Performance of the ePrime System for Cellulite
Clinical Study to Evaluate the Performance of the ePrime System for the Treatment of Cellulite
Status: Enrolling
Updated:  3/17/2016
Macrene Alexiades
mi
from
New York, NY
Performance of the ePrime System for Cellulite
Clinical Study to Evaluate the Performance of the ePrime System for the Treatment of Cellulite
Status: Enrolling
Updated: 3/17/2016
Macrene Alexiades
mi
from
New York, NY
Click here to add this to my saved trials
Performance of the ePrime System for Cellulite
Clinical Study to Evaluate the Performance of the ePrime System for the Treatment of Cellulite
Status: Enrolling
Updated:  3/17/2016
Girish Munavalli
mi
from
Charlotte, NC
Performance of the ePrime System for Cellulite
Clinical Study to Evaluate the Performance of the ePrime System for the Treatment of Cellulite
Status: Enrolling
Updated: 3/17/2016
Girish Munavalli
mi
from
Charlotte, NC
Click here to add this to my saved trials
Performance of the ePrime System for Cellulite
Clinical Study to Evaluate the Performance of the ePrime System for the Treatment of Cellulite
Status: Enrolling
Updated:  3/17/2016
David Goldberg
mi
from
Hackensack, NJ
Performance of the ePrime System for Cellulite
Clinical Study to Evaluate the Performance of the ePrime System for the Treatment of Cellulite
Status: Enrolling
Updated: 3/17/2016
David Goldberg
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Prevention of Post-Mastectomy Breast Pain Using Ambulatory Continuous Paravertebral Blocks
Prevention of Post-Mastectomy Breast Pain Using Ambulatory Continuous Paravertebral Blocks
Status: Enrolling
Updated:  4/7/2016
UCSD - Thornton Hospital
mi
from
La Jolla, CA
Prevention of Post-Mastectomy Breast Pain Using Ambulatory Continuous Paravertebral Blocks
Prevention of Post-Mastectomy Breast Pain Using Ambulatory Continuous Paravertebral Blocks
Status: Enrolling
Updated: 4/7/2016
UCSD - Thornton Hospital
mi
from
La Jolla, CA
Click here to add this to my saved trials
Comparison of Scar Results and Time for Closures of Scalp Defects Via Pulley Sutures or Layered Repairs
A Prospective, Randomized Study to Evaluate the Efficacy of Pulley Closures Compared to Intermediate or Complex Closures for Reconstruction of Scalp Surgical Defects
Status: Enrolling
Updated:  4/15/2016
Henry Ford Health System- Dermatology
mi
from
Detroit, MI
Comparison of Scar Results and Time for Closures of Scalp Defects Via Pulley Sutures or Layered Repairs
A Prospective, Randomized Study to Evaluate the Efficacy of Pulley Closures Compared to Intermediate or Complex Closures for Reconstruction of Scalp Surgical Defects
Status: Enrolling
Updated: 4/15/2016
Henry Ford Health System- Dermatology
mi
from
Detroit, MI
Click here to add this to my saved trials
Safety and Efficacy of Botulinum Toxin Type A Topical Gel for Lateral Canthal Lines
Status: Enrolling
Updated:  8/2/2016
Clinical Research Facility
mi
from
Coral Gables, FL
Safety and Efficacy of Botulinum Toxin Type A Topical Gel for Lateral Canthal Lines
Status: Enrolling
Updated: 8/2/2016
Clinical Research Facility
mi
from
Coral Gables, FL
Click here to add this to my saved trials
A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea
A Multi-center, Double-blind, Randomized, Vehicle-controlled, Parallel-group Study Comparing Metronidazole Gel 1%, to Metrogel® (Metronidazole Gel) 1% in the Treatment of Rosacea
Status: Enrolling
Updated:  11/29/2016
Clinical Research Facility
mi
from
Los Angeles, CA
A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea
A Multi-center, Double-blind, Randomized, Vehicle-controlled, Parallel-group Study Comparing Metronidazole Gel 1%, to Metrogel® (Metronidazole Gel) 1% in the Treatment of Rosacea
Status: Enrolling
Updated: 11/29/2016
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea
A Multi-center, Double-blind, Randomized, Vehicle-controlled, Parallel-group Study Comparing Metronidazole Gel 1%, to Metrogel® (Metronidazole Gel) 1% in the Treatment of Rosacea
Status: Enrolling
Updated:  11/29/2016
Clinical Research Facility
mi
from
San Diego, CA
A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea
A Multi-center, Double-blind, Randomized, Vehicle-controlled, Parallel-group Study Comparing Metronidazole Gel 1%, to Metrogel® (Metronidazole Gel) 1% in the Treatment of Rosacea
Status: Enrolling
Updated: 11/29/2016
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea
A Multi-center, Double-blind, Randomized, Vehicle-controlled, Parallel-group Study Comparing Metronidazole Gel 1%, to Metrogel® (Metronidazole Gel) 1% in the Treatment of Rosacea
Status: Enrolling
Updated:  11/29/2016
Clinical Research Facility
mi
from
Boca Raton, FL
A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea
A Multi-center, Double-blind, Randomized, Vehicle-controlled, Parallel-group Study Comparing Metronidazole Gel 1%, to Metrogel® (Metronidazole Gel) 1% in the Treatment of Rosacea
Status: Enrolling
Updated: 11/29/2016
Clinical Research Facility
mi
from
Boca Raton, FL
Click here to add this to my saved trials
A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea
A Multi-center, Double-blind, Randomized, Vehicle-controlled, Parallel-group Study Comparing Metronidazole Gel 1%, to Metrogel® (Metronidazole Gel) 1% in the Treatment of Rosacea
Status: Enrolling
Updated:  11/29/2016
Clinical Research Facility
mi
from
Clearwater, FL
A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea
A Multi-center, Double-blind, Randomized, Vehicle-controlled, Parallel-group Study Comparing Metronidazole Gel 1%, to Metrogel® (Metronidazole Gel) 1% in the Treatment of Rosacea
Status: Enrolling
Updated: 11/29/2016
Clinical Research Facility
mi
from
Clearwater, FL
Click here to add this to my saved trials
A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea
A Multi-center, Double-blind, Randomized, Vehicle-controlled, Parallel-group Study Comparing Metronidazole Gel 1%, to Metrogel® (Metronidazole Gel) 1% in the Treatment of Rosacea
Status: Enrolling
Updated:  11/29/2016
Clinical Research Facility
mi
from
Miami, FL
A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea
A Multi-center, Double-blind, Randomized, Vehicle-controlled, Parallel-group Study Comparing Metronidazole Gel 1%, to Metrogel® (Metronidazole Gel) 1% in the Treatment of Rosacea
Status: Enrolling
Updated: 11/29/2016
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea
A Multi-center, Double-blind, Randomized, Vehicle-controlled, Parallel-group Study Comparing Metronidazole Gel 1%, to Metrogel® (Metronidazole Gel) 1% in the Treatment of Rosacea
Status: Enrolling
Updated:  11/29/2016
Clinical Research Facility
mi
from
Miami, FL
A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea
A Multi-center, Double-blind, Randomized, Vehicle-controlled, Parallel-group Study Comparing Metronidazole Gel 1%, to Metrogel® (Metronidazole Gel) 1% in the Treatment of Rosacea
Status: Enrolling
Updated: 11/29/2016
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea
A Multi-center, Double-blind, Randomized, Vehicle-controlled, Parallel-group Study Comparing Metronidazole Gel 1%, to Metrogel® (Metronidazole Gel) 1% in the Treatment of Rosacea
Status: Enrolling
Updated:  11/29/2016
Clinical Research Facility
mi
from
Miramar, FL
A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea
A Multi-center, Double-blind, Randomized, Vehicle-controlled, Parallel-group Study Comparing Metronidazole Gel 1%, to Metrogel® (Metronidazole Gel) 1% in the Treatment of Rosacea
Status: Enrolling
Updated: 11/29/2016
Clinical Research Facility
mi
from
Miramar, FL
Click here to add this to my saved trials
A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea
A Multi-center, Double-blind, Randomized, Vehicle-controlled, Parallel-group Study Comparing Metronidazole Gel 1%, to Metrogel® (Metronidazole Gel) 1% in the Treatment of Rosacea
Status: Enrolling
Updated:  11/29/2016
Clinical Research Facility
mi
from
Ocala, FL
A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea
A Multi-center, Double-blind, Randomized, Vehicle-controlled, Parallel-group Study Comparing Metronidazole Gel 1%, to Metrogel® (Metronidazole Gel) 1% in the Treatment of Rosacea
Status: Enrolling
Updated: 11/29/2016
Clinical Research Facility
mi
from
Ocala, FL
Click here to add this to my saved trials
A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea
A Multi-center, Double-blind, Randomized, Vehicle-controlled, Parallel-group Study Comparing Metronidazole Gel 1%, to Metrogel® (Metronidazole Gel) 1% in the Treatment of Rosacea
Status: Enrolling
Updated:  11/29/2016
Clinical Research Facility
mi
from
Tampa, FL
A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea
A Multi-center, Double-blind, Randomized, Vehicle-controlled, Parallel-group Study Comparing Metronidazole Gel 1%, to Metrogel® (Metronidazole Gel) 1% in the Treatment of Rosacea
Status: Enrolling
Updated: 11/29/2016
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea
A Multi-center, Double-blind, Randomized, Vehicle-controlled, Parallel-group Study Comparing Metronidazole Gel 1%, to Metrogel® (Metronidazole Gel) 1% in the Treatment of Rosacea
Status: Enrolling
Updated:  11/29/2016
Clinical Research Facility
mi
from
Lexington, KY
A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea
A Multi-center, Double-blind, Randomized, Vehicle-controlled, Parallel-group Study Comparing Metronidazole Gel 1%, to Metrogel® (Metronidazole Gel) 1% in the Treatment of Rosacea
Status: Enrolling
Updated: 11/29/2016
Clinical Research Facility
mi
from
Lexington, KY
Click here to add this to my saved trials
A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea
A Multi-center, Double-blind, Randomized, Vehicle-controlled, Parallel-group Study Comparing Metronidazole Gel 1%, to Metrogel® (Metronidazole Gel) 1% in the Treatment of Rosacea
Status: Enrolling
Updated:  11/29/2016
Clinical Research Facility
mi
from
Watertown, MA
A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea
A Multi-center, Double-blind, Randomized, Vehicle-controlled, Parallel-group Study Comparing Metronidazole Gel 1%, to Metrogel® (Metronidazole Gel) 1% in the Treatment of Rosacea
Status: Enrolling
Updated: 11/29/2016
Clinical Research Facility
mi
from
Watertown, MA
Click here to add this to my saved trials
A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea
A Multi-center, Double-blind, Randomized, Vehicle-controlled, Parallel-group Study Comparing Metronidazole Gel 1%, to Metrogel® (Metronidazole Gel) 1% in the Treatment of Rosacea
Status: Enrolling
Updated:  11/29/2016
Clinical Research Facility
mi
from
Las Vegas, NV
A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea
A Multi-center, Double-blind, Randomized, Vehicle-controlled, Parallel-group Study Comparing Metronidazole Gel 1%, to Metrogel® (Metronidazole Gel) 1% in the Treatment of Rosacea
Status: Enrolling
Updated: 11/29/2016
Clinical Research Facility
mi
from
Las Vegas, NV
Click here to add this to my saved trials
A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea
A Multi-center, Double-blind, Randomized, Vehicle-controlled, Parallel-group Study Comparing Metronidazole Gel 1%, to Metrogel® (Metronidazole Gel) 1% in the Treatment of Rosacea
Status: Enrolling
Updated:  11/29/2016
Clinical Research Facility
mi
from
New York City, NY
A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea
A Multi-center, Double-blind, Randomized, Vehicle-controlled, Parallel-group Study Comparing Metronidazole Gel 1%, to Metrogel® (Metronidazole Gel) 1% in the Treatment of Rosacea
Status: Enrolling
Updated: 11/29/2016
Clinical Research Facility
mi
from
New York City, NY
Click here to add this to my saved trials
A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea
A Multi-center, Double-blind, Randomized, Vehicle-controlled, Parallel-group Study Comparing Metronidazole Gel 1%, to Metrogel® (Metronidazole Gel) 1% in the Treatment of Rosacea
Status: Enrolling
Updated:  11/29/2016
Clinical Research Facility
mi
from
High Point, NC
A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea
A Multi-center, Double-blind, Randomized, Vehicle-controlled, Parallel-group Study Comparing Metronidazole Gel 1%, to Metrogel® (Metronidazole Gel) 1% in the Treatment of Rosacea
Status: Enrolling
Updated: 11/29/2016
Clinical Research Facility
mi
from
High Point, NC
Click here to add this to my saved trials
A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea
A Multi-center, Double-blind, Randomized, Vehicle-controlled, Parallel-group Study Comparing Metronidazole Gel 1%, to Metrogel® (Metronidazole Gel) 1% in the Treatment of Rosacea
Status: Enrolling
Updated:  11/29/2016
Clinical Research Facility
mi
from
Raleigh, NC
A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea
A Multi-center, Double-blind, Randomized, Vehicle-controlled, Parallel-group Study Comparing Metronidazole Gel 1%, to Metrogel® (Metronidazole Gel) 1% in the Treatment of Rosacea
Status: Enrolling
Updated: 11/29/2016
Clinical Research Facility
mi
from
Raleigh, NC
Click here to add this to my saved trials
A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea
A Multi-center, Double-blind, Randomized, Vehicle-controlled, Parallel-group Study Comparing Metronidazole Gel 1%, to Metrogel® (Metronidazole Gel) 1% in the Treatment of Rosacea
Status: Enrolling
Updated:  11/29/2016
Clinical Research Facility
mi
from
Cincinnati, OH
A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea
A Multi-center, Double-blind, Randomized, Vehicle-controlled, Parallel-group Study Comparing Metronidazole Gel 1%, to Metrogel® (Metronidazole Gel) 1% in the Treatment of Rosacea
Status: Enrolling
Updated: 11/29/2016
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea
A Multi-center, Double-blind, Randomized, Vehicle-controlled, Parallel-group Study Comparing Metronidazole Gel 1%, to Metrogel® (Metronidazole Gel) 1% in the Treatment of Rosacea
Status: Enrolling
Updated:  11/29/2016
Clinical Research Facility
mi
from
Philadelphia, PA
A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea
A Multi-center, Double-blind, Randomized, Vehicle-controlled, Parallel-group Study Comparing Metronidazole Gel 1%, to Metrogel® (Metronidazole Gel) 1% in the Treatment of Rosacea
Status: Enrolling
Updated: 11/29/2016
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea
A Multi-center, Double-blind, Randomized, Vehicle-controlled, Parallel-group Study Comparing Metronidazole Gel 1%, to Metrogel® (Metronidazole Gel) 1% in the Treatment of Rosacea
Status: Enrolling
Updated:  11/29/2016
Clinical Research Facility
mi
from
Warwick, RI
A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea
A Multi-center, Double-blind, Randomized, Vehicle-controlled, Parallel-group Study Comparing Metronidazole Gel 1%, to Metrogel® (Metronidazole Gel) 1% in the Treatment of Rosacea
Status: Enrolling
Updated: 11/29/2016
Clinical Research Facility
mi
from
Warwick, RI
Click here to add this to my saved trials
A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea
A Multi-center, Double-blind, Randomized, Vehicle-controlled, Parallel-group Study Comparing Metronidazole Gel 1%, to Metrogel® (Metronidazole Gel) 1% in the Treatment of Rosacea
Status: Enrolling
Updated:  11/29/2016
Clinical Research Facility
mi
from
Mt. Pleasant, SC
A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea
A Multi-center, Double-blind, Randomized, Vehicle-controlled, Parallel-group Study Comparing Metronidazole Gel 1%, to Metrogel® (Metronidazole Gel) 1% in the Treatment of Rosacea
Status: Enrolling
Updated: 11/29/2016
Clinical Research Facility
mi
from
Mt. Pleasant, SC
Click here to add this to my saved trials
A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea
A Multi-center, Double-blind, Randomized, Vehicle-controlled, Parallel-group Study Comparing Metronidazole Gel 1%, to Metrogel® (Metronidazole Gel) 1% in the Treatment of Rosacea
Status: Enrolling
Updated:  11/29/2016
Clinical Research Facility
mi
from
Austin, TX
A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea
A Multi-center, Double-blind, Randomized, Vehicle-controlled, Parallel-group Study Comparing Metronidazole Gel 1%, to Metrogel® (Metronidazole Gel) 1% in the Treatment of Rosacea
Status: Enrolling
Updated: 11/29/2016
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials